<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0"><channel><title><![CDATA[TECHWORKSLAB Insights]]></title><description><![CDATA[TECHWORKSLAB Insights]]></description><link>https://techworkslab.hashnode.dev</link><generator>RSS for Node</generator><lastBuildDate>Sun, 22 Nov 2026 17:21:51 GMT</lastBuildDate><atom:link href="https://techworkslab.hashnode.dev/rss.xml" rel="self" type="application/rss+xml"/><language><![CDATA[en]]></language><ttl>60</ttl><item><title><![CDATA[What risk-proportional validation looks like on a real study]]></title><description><![CDATA[Our validation page makes a general case: validate the artifact and not the author, and let the rigor scale with the risk the output carries. That is easy…]]></description><link>https://techworkslab.hashnode.dev/what-risk-proportional-validation-looks-like-on-a-real-study</link><guid isPermaLink="true">https://techworkslab.hashnode.dev/what-risk-proportional-validation-looks-like-on-a-real-study</guid><category><![CDATA[clinical trials]]></category><dc:creator><![CDATA[TECHWORKSLAB]]></dc:creator><pubDate>Thu, 12 Nov 2026 04:20:32 GMT</pubDate><content:encoded><![CDATA[<p>Our validation page makes a general case: validate the artifact and not the author, and let the rigor scale with the risk the output carries. That is easy to agree with in the abstract and harder to run on a Monday, when the question is not whether rigor should scale but exactly how much rigor this particular output gets, and who decides. This piece takes the idea down to the level of one study and shows what it looks like in the work.</p>
<p>The mistake risk-proportional validation corrects is the flat checklist. A flat checklist treats every output the same. The primary efficacy table and a supportive demographics listing both get the same number of review passes, the same independent programming, the same sign-off. That feels fair and even safe, but it is neither. It spends the same scarce senior attention on an output that could change the read of the trial and on one that almost nobody will act on. Worse, it dilutes. When everything is high rigor, nothing is, because the reviewer cannot tell from the process which output actually deserved their hardest look.</p>
<h2>Tier by what the artifact feeds, not by type</h2>
<p>The first move is to tier outputs by consequence, and the useful question is not what kind of output it is but what decision it feeds. An analysis dataset that the primary endpoint is derived from sits at the top, because an error there propagates into the result the submission is built on. A safety table that a reviewer reads to judge a signal sits high too. A supportive listing that supplements a table already validated sits lower. A quality-of-life summary that is clearly secondary and clearly labeled as such sits lower still.</p>
<p>None of this is a judgment about effort or craft. The programmer who builds the supportive listing works just as carefully as the one who builds the primary ADaM. Tiering is a statement about where a residual error would do the most damage, and therefore where the heaviest independent checking is worth its cost. On a real study this usually sorts into three or four tiers, and the sort is written down and agreed before programming starts, not reverse-engineered after a deadline slips.</p>
<h2>What changes between tiers, and what never does</h2>
<p>It is worth being precise about what the tiering actually turns up and down, because the danger is that lower tier quietly comes to mean unchecked. It does not. What scales is the amount of independent duplication and the seniority of the eyes, not the existence of a check. Tier 1 gets a full independent implementation, the kind where a second programmer builds the derivation from the specification without looking at the first version, and gets full traceability from the collected field through to the reported number. Tier 3 gets a single careful programmed pass checked against its spec, because an independent rebuild of a supportive listing buys less assurance than the same hours spent sharpening the primary result.</p>
<p>Two things never scale down. The first is traceability as a record. Even a Tier 4 output should be reproducible from its inputs, with the version of the data, the code, and the environment captured, so that if anyone later asks how a number was produced there is an answer that does not depend on memory. The point of traceability is not a diagram, it is evidence you can stand on. The second is the review gate. A qualified person signs off on every output before it ships, at every tier. The tier changes how much independent machinery sits behind that person. It does not change the fact that a human owns the final call.</p>
<blockquote>
<p>Risk-proportional does not mean some outputs skip review. It means the heavy independent checking concentrates where an error would cost the most, while the human gate stays in front of everything.</p>
</blockquote>
<h2>Decide the tiers with a method, not a vote</h2>
<p>The obvious objection is that tiering is subjective, and a subjective tier is just a place to hide a corner that got cut. The defense is to assign tiers with a documented method rather than a hallway opinion. We score each output on the consequence of a residual error, how exposed the output is to review and action, and how likely a subtle error is to slip through given the derivation's complexity. That gives a repeatable basis for where an artifact lands, and it gives a reviewer something to challenge. The scoring approach is the same one behind FMEA risk scoring for a submission package, pointed at the individual output rather than the filing as a whole.</p>
<p>The payoff of writing it down is that the tiering becomes auditable. When a sponsor or a reviewer asks why the supportive listing got a lighter touch than the primary table, the answer is a recorded rationale, not a shrug. That is the difference between cutting rigor and allocating it. Cutting rigor is invisible and indefensible. Allocating rigor is visible, argued, and exactly what a risk-based framework asks a team to do.</p>
<h2>Why this holds up when AI is in the workflow</h2>
<p>Tiering becomes more valuable, not less, once a model is drafting some of the work. When a first draft of a derivation can appear in minutes, the scarce resource is no longer typing the first version, it is the independent checking that confirms the output is right. Risk-proportional validation tells you exactly where to spend that freed-up time: on the Tier 1 independent implementation and the Tier 1 traceability, where a model's plausible-but-wrong draft would do the most harm. The output gets the same gate whether a person or a model produced the draft. Tiering just tells you how hard to look.</p>
<p>If you want help setting up tiers that are written down, defensible, and tied to a human review gate rather than to a reputation, that is the core of our submission-readiness audit.</p>
<p><em>Originally published on the</em> <a href="https://techworkslab.com/insights-risk-proportional-validation-on-a-study"><em>TECHWORKSLAB blog</em></a><em>.</em></p>
]]></content:encoded></item></channel></rss>